Which advice would you give to someone who has just been diagnosed with 22q13 deletion / Phelan-McDermid Syndrome?

A diagnosis of 22q13 deletion / Phelan-McDermid Syndrome (PMS) can feel overwhelming, but you are not alone; early intervention focusing on speech therapy, physical therapy, and multidisciplinary medical support is the most effective way to improve long-term outcomes. By building a coordinated care team and connecting with the 35 members already sharing their journeys on DiseaseMaps.org, you can better navigate the unique developmental and neurological challenges associated with this condition.

What is the most important first step after a diagnosis of 22q13 deletion / Phelan-McDermid Syndrome?

The immediate priority is to establish a baseline of your loved one's health needs. 22q13 deletion / Phelan-McDermid Syndrome is a complex genetic condition caused by the loss of the SHANK3 gene, which leads to varying degrees of global developmental delay, absent or delayed speech, and low muscle tone (hypotonia). Because the clinical presentation of 22q13 deletion / Phelan-McDermid Syndrome is highly variable, there is no "one size fits all" roadmap. Start by requesting a comprehensive evaluation from a clinical geneticist to understand the specific size and location of the deletion, as this can provide insight into potential future health challenges.

How should I build a care team for 22q13 deletion / Phelan-McDermid Syndrome?

Managing 22q13 deletion / Phelan-McDermid Syndrome requires a "medical home" model where a primary care physician coordinates with various specialists. You will likely need to assemble a team that includes a neurologist (to manage potential seizures), a gastroenterologist (as reflux and constipation are common), and therapists specializing in neurodevelopmental conditions. Effective care for 22q13 deletion / Phelan-McDermid Syndrome relies on consistent communication between these specialists and your family to ensure that therapies are aligned with the individual's current developmental stage.

What are practical strategies for daily life and caregiver support?

Living with 22q13 deletion / Phelan-McDermid Syndrome often involves managing sensory processing differences and communication challenges. It is vital to prioritize self-care for the entire family to prevent burnout. Consider the following strategies for managing daily life:

• Utilize Alternative Communication: Implement augmentative and alternative communication (AAC) devices or sign language early to reduce frustration related to speech delays.


• Structure and Routine: Predictable daily schedules can significantly reduce anxiety for individuals with 22q13 deletion / Phelan-McDermid Syndrome.


• Seek Peer Support: Engage with organizations like the Phelan-McDermid Syndrome Foundation to share lived experiences and practical tips that clinical manuals often overlook.


• Document Everything: Keep a centralized binder or digital folder of all medical records, therapy reports, and school IEPs to streamline interactions with new providers.

How can I stay informed about research and financial resources?

Staying informed about 22q13 deletion / Phelan-McDermid Syndrome is essential for advocating for the best possible care. Many families find value in participating in natural history studies or patient registries, which help researchers understand the progression of the syndrome. For financial assistance, look into local disability benefits, Medicaid waivers for medically complex children, and disease-specific grants offered by rare disease foundations. Always verify that the information you find comes from reputable, peer-reviewed sources or established patient advocacy groups.

Next steps

• Consult with a clinical geneticist to review the specific genetic findings of the deletion.


• Connect with the 35 community members on DiseaseMaps.org to share resources and emotional support.


• Contact the Phelan-McDermid Syndrome Foundation to register in their patient database.


• Schedule a consultation with a speech-language pathologist and an occupational therapist to begin early intervention services.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Phelan-McDermid Syndrome


• Orphanet: 22q13.3 deletion syndrome (ORPHA:2849)


• Phelan-McDermid Syndrome Foundation (PMSF)


• OMIM (Online Mendelian Inheritance in Man): #606232 (Phelan-McDermid Syndrome)